A recent systematic review indicated that while reductions in fat mass and visceral adipose tissue are generally consistent in obese or overweight adults, changes in lean mass are variable, showing decreases, preservation, or increases [49]
While the scientific name might sound intimidating, the mechanism is quite clever
The percentage of patients receiving GLP-1 medications both before and after bariatric surgery also showed steady growth, rising from 0.5% in 2018 to 3.3% in 2023, calling into question the extent to which GLP-1s are a replacement versus a supplemental therapy
The practical bottom line: if you need a weight loss medication today, tirzepatide is the proven, available option with years of safety data
Fast, domestic shippingno border delays
This is particularly valuable for researchers managing semaglutide fatigue or other side effects that make injection day preparation difficult